John Frederick Ek, Chief Financial Officer at GenMark Diagnostics, Inc. (GNMK), sold 2,591 shares at $15.41 ($40K) on 2020-08-20, disclosed to the SEC on 2020-08-24.
Scheduled sale ($40k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.41 | 1,691 | $26K | 64.5% |
| 2 | $15.97 | 900 | $14K | 35.5% |
| Total | $15.60 avg | 2,591 | $40K | 100% |
| Filing → |
| GNMK | SELL | 2020-11-25 | $19K | — | Filing → |
| GNMK | SELL | 2020-11-20 | $23K | — | Filing → |
| GNMK | SELL | 2020-09-24 | $1.1M | — | Filing → |